United States · FDA National Drug Code directory
Tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1016_f623a735-841a-4e73-ae38-e4d5d27a055f
- Product NDC
- 71335-1016
- Form
- TABLET
- Composition / generic term
- Tizanidine
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20031211
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 112 TABLET in 1 BOTTLE (71335-1016-0) · 71335-1016-0
- 30 TABLET in 1 BOTTLE (71335-1016-1) · 71335-1016-1
- 60 TABLET in 1 BOTTLE (71335-1016-2) · 71335-1016-2
- 90 TABLET in 1 BOTTLE (71335-1016-3) · 71335-1016-3
- 120 TABLET in 1 BOTTLE (71335-1016-4) · 71335-1016-4
- 20 TABLET in 1 BOTTLE (71335-1016-5) · 71335-1016-5
- 45 TABLET in 1 BOTTLE (71335-1016-6) · 71335-1016-6
- 140 TABLET in 1 BOTTLE (71335-1016-7) · 71335-1016-7
- 84 TABLET in 1 BOTTLE (71335-1016-8) · 71335-1016-8
- 28 TABLET in 1 BOTTLE (71335-1016-9) · 71335-1016-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →